From studying psychedelics to legalizing drug paraphernalia and residue, Minnesota's new drug policies reach far beyond marijuana.
The state is enacting changes this year aimed at reducing overdoses and infections, including legalization measures that advocates called nation-leading. The DFL-controlled Legislature also boosted fentanyl-related penalties and approved requirements to ensure schools and police officers carry opioid overdose reversal medication.
"The stigma and the criminalization, especially of serious drugs, of opiates, kills people. And they don't have to die," said Rep. Aisha Gomez, DFL-Minneapolis, who pushed to legalize paraphernalia and drug residue. "It's about the humanity of people who use drugs."
Here are some of the major changes to state drug policies.
Psychedelic medicine task force
While the legal marijuana bill traveled a high-profile path through more than two dozen committees, a proposal to explore legalizing psychedelic drugs such as LSD, psilocybin mushrooms and MDMA — better known as ecstasy — got little fanfare before it was tucked in the broader health finance package. Under the new law, Minnesota will create a Psychedelic Medicine Task Force to advise the Legislature on the "legal, medical, and policy issues associated with the legalization of psychedelic medicine in the state."
Despite decades of stigma around psychedelics, a handful of states and municipalities across the United States are moving to decriminalize their use. Some of the biggest backers of legalizing psychedelics are veterans, who have found some success using the drugs to treat PTSD. The task force must include psychiatrists, psychologists and veterans who are still struggling after other treatment.
Task force members will be appointed by July 15 and their first report is due to the Legislature when it convenes the next legislative session in February.